The ASPREE Healthy Ageing Biobank Reaches 8,000 Australian participants
The ASPREE Healthy Ageing Biobank team marks the 8,000th participant to volunteer for the study with a delightful cake made by one of their talented research assistants.
Can aspirin lower Colon Cancer Risk in Women?
A leading Australian medical researcher recommends that healthy people of all ages should consult their GP prior to commencing aspirin for disease prevention. Professor Mark Nelson (pictured left) was commenting after new research suggested that aspirin may reduce the risk of women developing colon cancer. He said the study, which found that women who took…
Details
First study update in Melbourne’s West
The ASPREE (ASPirin in Reducing Events in the Elderly) study hosted a study update and morning tea at the Altona Senior Citizens Centre to celebrate reaching over 200 participants in the Melbourne’s western suburbs. Special guest Hobson’s Bay City Councillor Sandra Wilson- joined 100 local study participants and guests, and research staff at the celebration. Associate…
Details
North-west Victoria welcome for the ASPREE study
Mildura Mayor Glenn Milne and Councillor Sharyon Peart formally launched the ASPREE (ASPirin in Reducing Events in the Elderly) study in the regional city recently. Over 50 ASPREE participants, their family, friends, GPs, practice managers and other interested parties attended the event at the Monash Regional Clinical School in Mildura. ASPREE Executive Officer, Associate Professor Robyn…
Details
Aspirin and Melanoma in Post-Menopausal Women
Medical Oncologist Dr Andrew Haydon, who oversees cancer aspects of a world-first aspirin trial, ASPREE, said that the recent association between aspirin and a reduced risk of developing melanoma was a call for closer investigation of aspirin’s anti-tumour effect. Melanoma is the most deadly form of skin cancer and is on the rise in Australia.…
Details
First ASPREE study update in Launceston
The ASPREE (ASPirin in Reducing Events in the Elderly) study hosted a study update and morning tea at the Windsor Community Precinct on Friday 8th March to celebrate reaching 400 participants in the Launceston region. Special guest and Tamar Valley resident Peter Cundall – renowned horticulturalist and former host of the ABC program Gardening Australia –…
Details
ASPREE Milestone in Australia – 10,000 participants!
World-first Aspirin study reaches new milestone – 10,000 participants PRESS RELEASE: Melbourne, February 21 2013 – The largest primary prevention aspirin study ever undertaken in older people has reached an important milestone, signing up 10,000 participants in Australia. The landmark ASPREE (ASPirin in Reducing Events in the Elderly) study is investigating whether a daily low…
Details
An open letter on aspirin and AMD
31 January 2013 To ASPREE participants and interested parties Recently you may have heard press reports that suggested aspirin might worsen an infrequent type of the eye disease called age – related macular degeneration or AMD. This is a condition of the eyes that in advanced cases causes severe vision loss. We write to reassure…
Details
Aspirin and AMD study lacks robustness to change clinical practice
PRESS RELEASE Melbourne, January 23 2013 – Professor John McNeil, Head of Monash University’s Department of Epidemiology and Preventive Medicine and Lead Investigator of the ASPREE trial (pictured left) responds to the recent JAMA article study linking regular Aspirin Use and Age-Related Macular Degeneration (AMD): “The relationship between aspirin and AMD is complex and is…
Details
Lead Investigator gives the ‘Big Picture on Aspirin’
ASPREE Principal Investigator, Professor John McNeil speaks to the Australian Ageing Agenda about the ASPREE study and the mixed messages about aspirin… “Professor McNeil said because aspirin is the most widely used drug in the world, there was a lot of media reporting of research related to a wide range of different effects associated with it.…
Details